Oncopharmpod
Metastatic NSCLC Updates: Role of CTLA-4 inhibitors?
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:14:05
- More information
Informações:
Synopsis
We review the 5-year update of CheckMate 227 and the POSEIDON to generate the hypothesis that CLTA-4 inhibition has a role in PD-L1 negative metastatic NSCLC. CM 227 update: https://pubmed.ncbi.nlm.nih.gov/?term=36223558 POSEIDON: https://pubmed.ncbi.nlm.nih.gov/?term=36327426 Editorial: https://pubmed.ncbi.nlm.nih.gov/?term=36331243
